Our regulatory experts bring you up to speed on the European Commission release of a new help text file with information for completing the Manufacturer Incident Report (MIR) form.
Summative usability testing with Emergo by UL — trusted human factors validation testing expertise to support FDA compliance.
Is your human factors validation testing documentation compliant? Learn about key components, including risk analysis, protocols and test reports.
The Office of Inspections and Investigations (OII), part of the U.S. FDA, will expand its program pilot of unannounced inspections beyond India and China.
Read our regulatory experts’ timely summary of this latest medical device regulatory development from the European Commission
The Swiss Federal Assembly voted to approve Motion 20.3211, which mandated the Swiss Federal Council to adopt regulations to allow medical devices authorized by non-European regulators to enter the Swiss market.
An Emergo by UL Human Factors Specialist discusses when it is acceptable to include proxy (surrogate) participants in HF validation testing, the FDA’s perspective on proxy participants and additional considerations to keep in mind when recruiting proxy participants.
The South African Health Products Regulatory Authority (SAHPRA), announced two important Quality Management System developments.
Emergo by UL human factors specialists share guidelines for using and selecting drug label colors.